The Food and Drug Administration recently approved generic versions of antipsychotic Zyprexa Zydis, pain drug Exalgo, hypertension drug Catapres-TTS, allergy drug Astepro and attention deficit disorder drug Ritalin.
Ajanta Pharma also has launched a generic version of the antipsychotic Risperdal.
Mylan Inc. May 14 said it has received final approval from the FDA for its generic version of Eli Lilly & Co.'s Zyprexa Zydis (olanzapine) 5 mg, 10 mg, 15 mg and 20 mg orally disintegrating tablets (ODTs).
The Pittsburgh-based company also said it has launched the product.
Zyprexa Zydis is indicated for treating schizophrenia or the acute treatment of ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.